Abstract
Presents the results of many-year experimental studies, clinical trials, and medical use of drugs of a new pharmacological class: antihypoxants. Antihypoxants are perspective drugs of urgent medicine, which was demonstrated on various models (all types of hypoxia, myocardial, brain, renal, and liver ischemia, grave mechanical and thermal injuries, blood loss, etc.) and in patients with these states.
MeSH terms
-
Acute Disease
-
Adult
-
Animals
-
Antioxidants / therapeutic use*
-
Brain Ischemia / drug therapy
-
Burns / drug therapy
-
Cell Hypoxia
-
Child
-
Clinical Trials as Topic
-
Crush Syndrome / drug therapy
-
Cytochrome c Group / therapeutic use
-
Dogs
-
Emergencies
-
Fetal Hypoxia / drug therapy
-
Guanylthiourea / therapeutic use*
-
Heart Diseases / drug therapy
-
Humans
-
Hypoxia / drug therapy*
-
Hypoxia, Brain / drug therapy
-
Liver / blood supply
-
Liver Diseases / drug therapy
-
Phenyl Ethers / therapeutic use
-
Picolines / therapeutic use
-
Rabbits
-
Rats
-
Thiadiazoles / therapeutic use*
Substances
-
Antioxidants
-
Cytochrome c Group
-
Phenyl Ethers
-
Picolines
-
Thiadiazoles
-
olifen
-
emoxypine succinate
-
amtizol
-
Guanylthiourea